With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.13440-07-8,Di(naphthalen-1-yl)phosphine oxide,as a common compound, the synthetic route is as follows.
General procedure: A mixture of quinone monoketal (0.6 mmol), H-phosphine oxide(0.5 mmol), and catalyst (20 mol% of H2O for allylic substitution,20 mol% of Et3N for 1,6-substitution) was dissolved in toluene underN2 atmosphere, stirred at 100 C or 80 C for 12 h. Uponcompletion of the reaction, the mixture was concentrated undervacuum. Removal of the solvent under a reduced pressure gave thecrude product; pure product was obtained by passing the crudeproduct through a short silica gel column using Hexane/EtOAc(2:1-5:1) as eluent., 13440-07-8
13440-07-8 Di(naphthalen-1-yl)phosphine oxide 23110917, achiral-phosphine-ligands compound, is more and more widely used in various.
Reference£º
Article; Xiong, Biquan; Wang, Gang; Zhou, Congshan; Liu, Yu; Yang, Chang-An; Zhang, Panliang; Tang, Kewen; Zhou, Quan; Journal of Organometallic Chemistry; vol. 885; (2019); p. 21 – 31;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate